Adenoviral vectors having a protein IX deletion
AssigneeCanji, Inc.
InventorsRichard Gregory, Ken Wills, Daniel Maneval
Life of this patent
Estimating the term…
Loading patent…
AssigneeCanji, Inc.
InventorsRichard Gregory, Ken Wills, Daniel Maneval
Estimating the term…
This invention provides a recombinant adenovirus expression vector characterized by the partial or total deletion of the adenoviral protein IX DNA and having a gene encoding a foreign protein or a functional fragment or mutant thereof. Transformed host cells and a method of producing recombinant proteins and gene therapy also are included within the scope of this invention. Thus, for example, the adenoviral vector of this invention can contain a foreign gene for the expression of a protein effective in regulating the cell cycle, such as p53, Rb, or mitosin, or in inducing cell death, such as the conditional suicide gene thymidine kinase. (The latter must be used in conjunction with a thymidine kinase metabolite in order to be effective).
1-31. (canceled)
A DNA segment comprising an adenoviral ITR and a p53 coding region, the coding region positioned under the control of a CMV promoter.
Dependencies are inferred from the claim text.